AOAndré Oliveira

André Oliveira

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


André Oliveira has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Leukocyte differential count to unveil inflammatory and immunosuppression response in critically ill patients

    by André Caetano Oliveira, João Rodrigo Barreiros Gargaté Soares Ferreira, Luís Silva, Margarida Vera-Cruz, João Gonçalves-Pereira

  • Open Access

    Phenotypic Characterization of Intensive Care Patients With Infections: A Pilot Study of Host and Pathogen-Based Cluster Analysis

    by André Oliveira, Ana Rita Fernandes, Tânia F Mendes, João Gonçalves-Pereira

    Introduction: Sepsis is a prevalent, albeit complex, disorder among critically ill patients and a “one-size-fits-all” approach does not seem applicable. Host intrinsic characteristics and microorganisms’ particularities may influence response to therapy and outcomes. Attempting to group patients and microorganism characteristics may be an important step in developing and facilitating personalized infection treatment plans. This work intends to identify infected patients’ clusters using clinical data that includes infection determinants: the isolated pathogen and the site of infection.


  • Open Access

    Infectious Foci, Comorbidities and Its Influence on the Outcomes of Septic Critically Ill Patients

    by Ana Maria Oliveira, André Oliveira, Raquel Vidal, João Gonçalves-Pereira

    Sepsis is among the most frequent diagnoses on admission to the intensive care unit (ICU). A systemic inflammatory response, activated by uncontrolled infection, fosters hypoperfusion and multiorgan failure and often leads to septic shock and mortality. These infections arise from a specific anatomic source, and how the infection foci influence the outcomes is unknown. All patients admitted to the ICU of Hospital de Vila Franca de Xira, between 1 January 2017 and 31 June 2023, were screened for sepsis and categorized according to their infection foci. During the study period, 1296 patients (32.2%) had sepsis on admission. Their mean age was 67.5 ± 15.3 and 58.1% were male; 73.0% had community-acquired infections. The lung was the main focus of infection. Septic shock was present in 37.9% of the patients and was associated with hospital mortality. Severe imbalances were noted in its incidence, and there was lower mortality in lung infections. The hospital-acquired infections had a slightly higher mortality but, after adjustment, this difference was non-significant. Patients with secondary bacteremia had a worse prognosis (one-year adjusted hazard ratio of 1.36, 95% confidence interval 1.06–1.74, p = 0.015), especially those with an isolated non-fermenting Gram-negative infection. Lung, skin, and skin structure infections and peritonitis had a worse prognosis, whilst urinary, biliary tract, and other intra-abdominal infections had a better one-year outcome.


  • Open Access

    A prolonged intensive care unit stay defines a worse long-term prognosis – Insights from the critically ill mortality by age (Cimba) study

    by Ana Rita Rodrigues, André Oliveira, Tatiana Vieira, Rui Assis, Catarina Lume, João Gonçalves-Pereira, Susana M. Fernandes


  • Open Access

    Atrial Fibrillation in Critically Ill Patients: Incidence and Outcomes

    by Sofia B. Paula, André Oliveira, João Melo e Silva, André F. Simões, João Gonçalves-Pereira

    Background: Atrial fibrillation (AF), either chronic or new onset, is common in critically ill patients. Its epidemiology and relationship with clinical outcomes are poorly known. Objective: To understand the burden of AF in patients admitted to the ICU and its impact on patients’ outcomes. Methods: This is a single-center, retrospective cohort study evaluating all patients with AF admitted to a non-cardiac intensive care unit over the course of 54 months. Clinical outcomes were evaluated in the short (hospital discharge) and long term (two-year follow-up). The hazard ratio (HR) with 95% CI was computed for the whole population as well as for propensity score-matched patients, with or without AF. Results: A total of 1357 patients were screened (59.1% male), with a mean age of 75 ± 15.2 years, length of intensive care unit stay of 4.7 ± 5.1 days, and hospital mortality of 26%. A diagnosis of AF was found in 215 patients (15.8%), 142 of whom had chronic AF. The hospital all-cause mortality was similar in patients with chronic or new-onset AF (31% vs. 28.8%, p = 0.779). Patients with AF had higher in-hospital, one-year, and two-year crude mortality (30.2% vs. 22.9%, p = 0.024; 47.9% vs. 35.3%, p = 0.001; 52.6% vs. 38.4%, p < 0.001). However, after propensity score matching (N = 213), this difference was no longer significant for in-hospital mortality (OR: 1.17; 95% CI: 0.77-1.79), one-year mortality (OR: 1.38; 95% CI: 0.94-2.03), or two-year mortality (OR: 1.30; 95% CI: 0.89-1.90). Conclusions: In ICU patients, the prevalence of AF, either chronic or new-onset, was 15.8%, and these patients had higher crude mortality. However, after adjustment for age and severity on admission, no significant differences were found in the short- and long-term mortality.